Enolase isozymes in seminoma

Area of Science:

• Oncology
• Biochemistry
• Cancer Biomarkers

Background:

• Seminoma is a common testicular germ cell tumor.
• Enolase isoenzymes, alpha-enolase and gamma-enolase, play roles in cellular metabolism and cancer.
• Understanding enolase expression in seminoma is crucial for identifying diagnostic and prognostic markers.

Purpose of the Study:

• To quantify alpha- and gamma-enolase concentrations in normal testicular and seminoma tissues.
• To investigate the correlation between tissue enolase levels and serum enolase concentrations in seminoma patients.
• To evaluate the utility of serum gamma-enolase as a biomarker for seminoma staging and treatment monitoring.

Main Methods:

• Enzyme immunoassay was used to determine alpha- and gamma-enolase concentrations in tissue samples.
• Immunohistochemistry was employed to localize gamma-enolase expression within seminoma tissues.
• Serum gamma-enolase levels were measured in patients with seminoma at various stages and after treatment.

Main Results:

• Alpha-enolase concentrations were higher in seminoma tissue compared to normal testis.
• Gamma-enolase concentrations were significantly elevated in seminoma tissue and positive in 75% of tumor cells.
• Serum gamma-enolase levels were elevated in 75% of seminoma patients, with higher detection rates in advanced stages.
• Serum gamma-enolase levels decreased significantly after treatment.

Conclusions:

• Elevated serum gamma-enolase in seminoma patients originates from increased gamma-enolase expression in tumor tissues.
• Serum gamma-enolase serves as a potential biomarker for staging seminoma.
• Serum gamma-enolase can be utilized for monitoring the clinical course and treatment response in seminoma patients.